ArticleJAMA network open2023

Association Between Survival and Metastatic Site in Mismatch Repair-Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab.

Bahar Saberzadeh-Ardestani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.